Company / Revenue per Share
Oruka Therapeutics, Inc. Revenue per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-
vs FY2022
Sector context
#146 of 154
Health Care
What the data says
Remained stable around $0.00 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 154
▼
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
| FY2015 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026